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Nijmegen, the Netherlands; Rochester, Minnesota, USA; Utrecht, the Netherlands; Chapel Hill, North Carolina, USABackground and Aims: Although the rule of 3 is recommended to minimize the risk of perforation when esoph-
ageal dilation is performed using bougie dilators, there are no data to validate its use. Our aim was to investigate
the association between the rule of 3 and adverse events (AEs) in esophageal dilation.
Methods: A retrospective chart review in patients who underwent esophageal bougie or balloon dilation between
December 1991 and February 2013 at a tertiary hospital was performed. Data collection included patient demo-
graphics, stricture and procedural characteristics, AEs, and follow-up. Univariate logistic regression models were
used to assess the risk of AEs and perforations.
Results: A total of 297 patients (median age, 63 years; 60% men) underwent 2216 esophageal bougie or balloon
dilations. Major AEs occurred in 22 (1%) dilation sessions, including 11 (0.5%) perforations, 4 (0.2%) fistulas,
3 (0.1%) hospitalizations for pain management, 2 (0.09%) clinically significant hemorrhages, 1 (0.04%) fever,
and 1 (0.04%) tracheoesophageal voice prosthesis leak. Mean duration of treatment was 43.2 months (standard
deviation, 47.7 months). Most strictures were benign (n Z 275; 93%) and complex in nature (n Z 198; 67%).
Non-adherence to the rule of 3 occurred in 190 (13%) dilations with bougie dilators. Non-adherence was not asso-
ciated with a higher rate of major AEs (1/190, 0.5% vs 15/953, 1.6%; PZ .18) and perforations (0/190, 0% vs 7/952,
0.7%; PZ .18). Gender, complex strictures, location of the stricture, type of dilator, and additional interventions
were also not associated with major AEs or perforations. However, malignant strictures were associated with an
increased risk of major AEs (odds ratio, 3.5; 95% confidence interval, 1.1-12.0) and perforations (odds ratio, 8.3;
95% confidence interval, 2.2-31.9).
Conclusions: Non-adherence to the rule of 3 does not appear to increase the risk of AEs, particularly perforation,
after esophageal dilation using bougie dilators. Caution is needed with the dilation of malignant strictures, as
there is an increased risk of perforations and AEs. However, large prospective studies are needed to verify the
results of this study. (Gastrointest Endosc 2017;85:332-7.)INTRODUCTION
Esophageal dilation is used to treat strictures of the
esophagus from a variety of benign and malignant disor-
ders. In the past, peptic strictures were the most frequent
reason for dilation; however, there has been a decrease inns: AE, adverse event; ASGE, American Society for Gastroin-
oscopy; PDT, photodynamic therapy; TTS, through-the-scope.
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Nowadays, esophageal strictures from malignancy, post-
surgery, caustic ingestion, radiation therapy, photody-
namic therapy (PDT), wide mucosectomy, eosinophilic
esophagitis, and Schatzki rings are increasingly encoun-
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TABLE 1. Characteristics of the patients (n [ 297) and procedures
(n [ 2216)
Characteristic Number (%)
Sex
Males 177 (60)
Females 120 (40)
Age at first dilation (years), median (range) 63 (18-97)
Experience of endoscopist
10 dilations 2023 (91.3)
<10 dilations 193 (8.7)
Sedation
Midazolam 1852 (83.6)
General anesthesia 249 (11.2)
Propofol 82 (3.7)
Unknown 33 (1.5)
Type of dilator
Bougie 1414 (63.8)
Balloon 606 (27.3)
Combination 180 (8.1)
Unknown 16 (0.7)
Grooteman et al Adverse events in esophageal dilationreduce the risk of pulmonary aspiration, maintain oral
nutrition, and facilitate passage of endoscopes.4 Caustic,
radiation-induced, post-surgical, and PDT-induced stric-
tures are more likely to remain refractory to dilation.5
Adverse events (AEs) of dilation include perforation,
bleeding, pulmonary aspiration, and fistula formation.
Perforation occurs in 0.1% to 2.6% of procedures and is
the most feared AE with a mortality rate as high as
20%.6,7 Risk factors for dilation-induced perforation include
eosinophilic esophagitis, complex strictures, and malignant
stenoses.6,8
Balloon and bougie dilators are used to perform dilation.
As opposed to radial forces incurred by balloon dilators,
bougie dilators also generate longitudinal forces. This dif-
ference has never been proven to have any effect on the
rate of AEs or clinical outcome between Savary (bougie)
and through-the-scope (TTS) balloon dilators.9-12 Theoret-
ically, more dilation sessions are needed with bougie dila-
tors because the rule of 3 may limit the number of
sessions. The rule of 3 states that no more than 3 dilators
of progressively increasing diameter should be passed after
moderate resistance is encountered. This rule is applicable
to bougienage alone and was intended to preclude over-
aggressive dilation and consequent perforation. Although
the rule of 3 makes common sense, it is not evidence
based. One study suggests that dilation using larger incre-
mental diameters may be safe for simple strictures.13
This single-center retrospective study assesses over
2200 esophageal dilations and the association between
the rule of 3 and AEs during esophageal bougienage.PATIENTS AND METHODS
A retrospective chart review was performed of patients
who underwent esophageal dilation between December
1991 and February 2013 at Mayo Clinic, Rochester, Minne-
sota. The following data were extracted: demographics, indi-
cation for dilation, stricture characteristics, technique of
endoscopic dilation, adherence to the rule of 3, AEs, need
for additional treatment, and post-treatment outcomes.
The definition of the rule of 3 for bougie dilators was
taken from the American Society for Gastrointestinal
Endoscopy (ASGE) guideline on esophageal dilation: after
moderate resistance is encountered, no more than 3
consecutive dilators in increments of 1 mm should be
passed in a single session.14 Consequently, when the
degree of resistance was not reported, adherence to the
rule of 3 was scored as “unknown.” This rule is not
applicable for balloon dilation, as there is no degree of
resistance felt during the dilation. We subjectively
defined adherence to the rule of 3 for balloon dilation
when the difference in size between the first and last
balloon was 3 mm. AEs were defined by the ASGE
consensus for endoscopic AEs.15 AEs after dilation in
another facility and those due to an esophageal stentwww.giejournal.org(eg, stent migration) or progression of disease were not
included. Pneumatic balloon dilation in patients with
achalasia were excluded. Strictures were defined as
simple or complex using previous definitions.14 Complex
strictures are asymmetric, with a diameter 12 mm, or
inability to pass an endoscope. The study was approved
by the Institutional Review Board, and all patients gave
written informed consent for the endoscopic procedures.
Sample size was calculated based on the assumption
that the AE prevalence would be 3% with non-adherence
and 1% with adherence to the rule of 3. With a power of
90% and a significance level of .05, the target sample size
was 2000 dilations. Descriptive statistics were reported as
median or mean and range for continuous variables. The
c2 test and the Fisher exact test were used for categorical
variables and the Student t test was used for continuous
variables to sub-analyze the value of the rule of 3 in dila-
tions with bougie dilators. Univariate logistic regression
models were used to model the risk of AEs and perfora-
tions. Odds ratios (ORs) and 95% confidence intervals
(95% CI) were used to describe the associations. A
P value .05 was considered statistically significant. The
analyses were performed using JMP software, version 9
(SAS Institute Inc., Cary, NC).RESULTS
Of 1306 eligible patients, 297 patients (60% men) were
randomly selected for analysis (Table 1). The stricture
characteristics are listed in Table 2. The median age atVolume 85, No. 2 : 2017 GASTROINTESTINAL ENDOSCOPY 333
TABLE 2. Stricture characteristics
Characteristic Number (%)
Benign/malignant
Benign 275 (93)
Malignant 22 (7)
Simple/complex
Simple 99 (33)
Complex 198 (67)
Cause
Radiation 64 (22)
Post-surgery 59 (20)
Schatzki ring 22 (7)
Malignant 21 (7)
Unknown 19 (6)
Peptic 17 (6)
Post-endotherapy 17 (6)
Cricopharyngeal bar 17 (6)
Caustic 9 (3)
Other 52 (17)
Location
Proximal 138 (47)
Mid 47 (16)
Distal 74 (25)
Anastomosis 22 (7)
Unspecified 16 (5)
TABLE 3. Identification of variables associated with major AEs
Odds
ratio
95% confidence
interval P value
Gender 1.1 0.5-2.6 .85
Simple vs complex 0.95 0.3-2.8 .92
Benign vs malignant 3.5 1.1-12.0 .047*
Proximal vs distal strictures 0.7 0.2-3.4 .70
Bougie vs balloon
(missing n Z 16)
0.4 0.1-1.4 .15
According rule of 3
(missing n Z 9)
0.5 0.2-1.5 .20
>3 mm dilation
(missing n Z 12)
0.7 0.3-1.6 .38
Additional intervention
(missing n Z 6)
1.2 0.5-2.9 .74
*Statistically significant.
TABLE 4. Identification of variables associated with perforations
Odds
ratio
95% confidence
interval P value
Gender 1.9 0.6-6.2 .29
Simple vs complex 2.1 0.3-16.5 .48
Benign vs malignant 8.3 2.2-31.9 .002*
Proximal vs distal strictures 1.0 0.1-9.2 .99
Bougie vs balloon
(missing n Z 16)
1.0 0.3-3.9 .99
According rule of 3
(missing n Z 9)
0.8 0.2-3.3 .80
>3 mm dilation
(missing n Z 12)
0.6 0.2-2.2 .44
Additional intervention
(missing n Z 6)
2.7 0.7-10.1 .14
*Statistically significant.
Adverse events in esophageal dilation Grooteman et altime of first dilation was 63 years (range, 18-97 years).
Forty-seven (16%) patients had undergone previous dila-
tions at other facilities. All dilations were performed by
or with a staff physician who dictated the endoscopy
report. Mean duration of treatment was 43.2 months (stan-
dard deviation, 47.7 months). Most of the strictures were
benign (93%) and complex (67%) in nature. Only 53
(18%) strictures were ulcerative at the time of dilation.
The most common stricture location was the proximal
esophagus, and the more common causes were radiation
and post-surgery.
A total of 2216 dilation sessions were performed. A
major AE occurred in 22 (1.0%) of these procedures: 11
(0.5%) perforations, 4 (0.2%) fistulas, 3 (0.1%) hospitaliza-
tions for pain management, 2 (0.09%) clinically significant
bleedings, 1 (0.04%) fever, and 1 (0.04%) tracheoesopha-
geal voice prosthesis leak. Table 3 shows the association
of major AEs for 8 potential risk factors. Malignant
structures were found to be associated with major AEs
(OR, 3.5; 95% CI, 1.1-12.0). All other factors, including
location of the stricture, complex stricture, type of
dilator, non-accordance to the rule of 3, dilation of more
than 3 mm, and additional procedures performed, were
not associated with major AEs.334 GASTROINTESTINAL ENDOSCOPY Volume 85, No. 2 : 2017Perforations occurred in 11 (0.5%) of all dilation proced-
ures. One perforation occurred before dilation was
performed when the trachea was cannulated instead of
the esophagus. Table 4 shows the association of the
potential risk factors for perforation. Only malignant
structures were associated with the occurrence of
perforation (OR, 8.3; 95% CI, 2.2-31.9); all the other
factors were not found to be associated with perforation.
A sub-analysis for the rule of 3 and dilations greater than
3 mm for bougie dilators was performed. There was no dif-
ference in incidence of AEs (1/190, 0.5% vs 15/953, 1.6%,
P Z .18) or perforations (0/190, 0% vs 7/952, 0.7%,
P Z .18) in dilation sessions whether the rule of 3 was
adhered to or not (Table 5). Neither was a difference in
AEs or perforations found for dilations greater than 3 mm.
The rates of perforation according to the cause of stric-
ture are shown in Figure 1. A higher rate of perforations
was seen in patients with strictures of unknown cause,www.giejournal.org
TABLE 5. Sub-analysis of bougie dilators for adverse events and perforations (%)
AE: yes, n [ 17 AE: no, n [ 1397 P value
>3 mm dilation 9 (52.9) 862 (61.7)
3 mm dilation (missing n Z 1) 8 (47.1) 534 (38.2) .46
According to rule of 3 15 (88.2) 938 (67.2)
Not according to rule of 3 1 (5.9) 189 (13.5)
Unknown 1 (5.9) 270 (19.3) .18
Perforation: yes, n Z 7 Perforation: no, n Z 1407
>3 mm dilation 4 (57.1) 866 (61.5)
3 mm dilation (missing n Z 2) 3 (42.9) 539 (38.3) .81
According to rule of 3 7 (100) 945 (67.2)
Not according to rule of 3 0 (0) 190 (13.5)
Unknown (missing n Z 1) 0 (0) 271 (19.3) .18
AE, Adverse event.
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Figure 1. Relationship between proportion of perforations and cause of the stricture.
Grooteman et al Adverse events in esophageal dilationradiation-induced strictures, and post-surgery strictures.
Three perforations occurred in 2 patients with strictures
of unknown cause. These patients had multiple dilations
with multiple biopsy specimens taken. These dilations
took place after 2000. The specimens did not result in a
diagnosis, which makes it unlikely that these 2 patients
had eosinophilic esophagitis. The percentage of perfora-
tions was equally distributed to the number of the dilation
session (Supplementary Fig. 1, available online at www.
giejournal.org). The risk of perforation did not differ
among the dilation sessions.
At the time of analysis, 98 patients (33%) were
deceased. Median age at the time of death was 72 years
(range, 29-100 years). The cause of death was unknown
in 14 patients (14%). Mortality was not related to dilation
in most cases (81%), but 5 (5%) died within 1 month of
the dilation procedure for which the exact cause of deathwww.giejournal.orgis unknown. In 4 of these patients, death was not related
to the initial dilation, because no additional procedures
were performed and no AEs were reported during or after
the dilation. One patient was a 71-year-old woman with
esophageal cancer. Her dilation was complicated by a
perforation for which a covered esophageal stent was
placed; she was hospitalized for 5 days and died 2.5 weeks
after discharge.DISCUSSION
This study shows that non-adherence to the rule of 3 is
not associated with a higher rate of AEs or perforations
after esophageal dilation. The only factor that was associ-
ated with an increased risk of AEs and perforations was
a malignant stricture, which is in accordance with theVolume 85, No. 2 : 2017 GASTROINTESTINAL ENDOSCOPY 335
Adverse events in esophageal dilation Grooteman et alliterature.9,14 Complex strictures are considered to be a
risk factor for perforation, but this is mostly based on a
retrospective study in which all perforations occurred after
Maloney dilation and half of the strictures were malignant.
Complex strictures were overrepresented in this study, but
we did not find an association between complex strictures
and AEs. Overall, the importance of complex strictures
as a risk factor for AEs might be overestimated. A trend
was seen whereby an additional esophageal therapeutic
intervention was performed during the same session. In
patients undergoing multiple dilations, the perforation
rate did not differ between dilation sessions.
Strengths of this study include the large number of dila-
tions performed, the investigation of other variables in
addition to the rule of 3, and the preponderance of com-
plex strictures. Although another study suggested that it
was safe to dilate more than 3 mm in one session, most
of the patients in that study had simple strictures.13 In
our study, most of the patients had complex strictures.
We found that dilation to >3 mm in one session was not
associated with more AEs, particularly perforation. Similar
to the other studies, we did not find a difference in the
rate of AEs or perforations between bougie and balloon
dilators.9-12 The perforation rate found in our study
(0.5%) is comparable with those reported in the literature.
However, most patients included in the randomized
studies comparing balloon and bougie dilation had benign
strictures with lower AE rates.10,12
Our study is limited by its retrospective nature. We
cannot exclude the possibility that AEs were not reported
to our center after the patient was discharged from our
institution. This could have led to an underestimation of
the AE rate. In addition, application of objective measures
to the rule of 3, which is subjective and based on tactile
sensation, is fraught with difficulties. Moreover, there
could be reporting bias by endoscopists if the rule of 3
was not precisely followed, as emphasized frequently in
guidelines. Thus, there may be underreporting of lack of
adherence. Furthermore, there are different definitions
of the rule in different guidelines.4,14 We cannot exclude
eosinophilic esophagitis as a confounder in this study.
However, we do not think this had a large impact on our
study, because biopsy specimens of strictures of unknown
cause did not indicate a diagnosis of eosinophilic esopha-
gitis after this became a recognized entity. Finally, it is
important to address the inclusion of balloon dilations. In
clinical practice, many physicians also use the rule of 3 in
balloon dilation. We hypothesized that if the rule of 3
added value in decreasing AEs, it would apply to both
bougie and balloon dilation. However, if this hypothesis
is incorrect, the inclusion of balloon dilations decreases
the power of the study.
Based on these results, we believe that the rule of 3
does not need to be used when esophageal dilation is per-
formed with bougie dilators. However, it still serves as a
useful conservative guide, but might need to be updated336 GASTROINTESTINAL ENDOSCOPY Volume 85, No. 2 : 2017to current practice. In our experience, initial dilation is
started at a diameter of 1 to 2 mm larger than the esti-
mated diameter of the stricture. The latter is based on
whether a normal caliber (depending on type, 9-10 mm)
or small caliber (4-5 mm) endoscope is able to pass the
stricture. Dilation is continued until “firm” resistance is
felt in the case of bougie dilation and/or the amount of
blood at the end of the dilator is more than “slight.” The
same applies for balloon dilation, but the degree of resis-
tance is assessed by moving the endoscope and the
inflated balloon back and forth within the stricture at
each diameter. At the end of dilation, endoscopy is
performed to confirm the presence of a tear and exclude
major bleeding or a perforation.
As an alternative to the rule of 3, it is proposed to perform
a prospective study investigating a “rule of 6,” where 3
consecutive bougie dilations are performed with incre-
ments of 2 mm each. Our study suggests that this may be
a reasonable alternative to the rule of 3 for most patients.
Nonetheless, it is important to emphasize that caution is
needed when performing dilation of malignant strictures.
The same applies for other specific diseases such as eosin-
ophilic esophagitis.8 Unfortunately, these patients were
not well represented in our study population. These
findings make clear that the proposed “rule of 6” should
not be applied to every patient, and exceptions for
patients with specific risk factors for AEs must be made.
In conclusion, adherence to the rule of 3 does not
appear to reduce the risk for AEs, including esophageal
perforation, after esophageal dilation with bougie dilators.
Malignancy of the stricture is associated with an increased
risk of AEs and perforations. Prospective trials would be
useful to support these findings.REFERENCES
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Supplementary Figure 1. Percentage of perforations distributed according to the dilation session.
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